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Abstract
Exercise may modulate lipolysis via leading to natriuretic peptide secretion and beta-adrenergic activation. Adiponectin, an adi-
pose-secreted multifunctional signaling protein, may be the missing link between exercise and lipolytic activity. In this study, we 
aimed to investigate the effects of supramaximal exercise on plasma levels of adiponectin, atrial natriuretic peptide (ANP), and B-
type natriuretic peptide (BNP) in healthy humans. Thirty-one healthy young adult volunteers (male/female, 15/16; mean age±SD, 
20.7±1.7 years) underwent a 30-second Wingate anaerobic exercise test on a cycle ergometer and venous blood sampling before 
and after the exercise test. Plasma ANP and BNP levels were assayed by radioimmunoassay, whereas adiponectin levels were 
assayed by enzyme-linked immunosorbent assay. Systolic and diastolic blood pressures, heart rate, hematocrit levels and blood 
lactate were also measured before and after exercise. The mean plasma adiponectin level significantly increased following a 
30-second anaerobic exercise test compared to resting level (17.45±4.70 vs 31.29±5.16 μg/mL, respectively, p<0.001). The mean 
plasma ANP and BNP levels remained comparable before and after the 30-second anaerobic exercise. A 30-sec supramaximal 
exercise session enhanced circulating adiponectin levels in both gender groups, whereas ANP and BNP levels exerted non-
significant alterations. We suggest that acute anaerobic exercise may affect secretory function of adipose tissue which seems 
not related with natriuretic peptide secretion.  
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Introduction
The cardiac natriuretic hormones comprise of atrial natriuretic 
peptide (ANP), B-type natriuretic peptide (BNP), C-type natriu-
retic peptide (CNP), dendroaspis natriuretic peptide (DNP) and 
urodilatin. These peptides share some common structural and 
biologic properties such as diuresis, natriuresis, vasodilation and 
inhibition of ventricular myosites. Their activities may also dif-
fer to some extent. ANP is released from atrial cardiomyocytes 
in response to intra-atrial pressure increase and BNP is released 
from ventricular cardiomyocytes in response to stretching and 
myocardial ischemia or damage (1). Elevated plasma BNP levels 
in patients with chronic cardiac failure have been suggested as 
the marker of ventricular ejection fraction and exercise capac-
ity (2). Dynamic exercise increases BNP levels in patients with 
heart failure (3, 4). BNP levels may also increase in marathon 
runners during long-term strenuous exercise (5). On the other 
hand, blood BNP was within normal levels in football players 
and there was no relationship between left ventricular hyper-
throphy, blood BNP and cardiac troponin C (6).
Recent studies revealed lipid mobilization and lipolysis ef-
fects of natriuretic peptides on adipocytes (7, 8). ANP and BNP 
play role in the regulation of lipolysis in isolated adipocytes 
through binding A-type guanylyl cyclase receptor and activating 
hormone-sensitive lipase (9). In addition, exercise may modu-
late lipolysis via leading to natriuretic peptide secretion and 
beta-adrenergic activation. Thus, adiponectin may be the miss-
ing link between exercise and lipolytic activity. The relationship 
of adiponectin and natriuretic peptides seems to be more com-
plicated. Exogenous ANP administration resulted in elevation 
of plasma adiponectin levels of patients with heart failure (10). 
In a study, NT-proBNP and adiponectin levels were in positive 
correlation (11).
In this study, we tested the hypothesis that an acute supramax-
imal exercise bout alters plasma ANP, BNP and adiponectin lev-
els in healthy female and male subjects. We also investigated the 
relationship between blood pressure, adiponectin, ANP, BNP, 
lactate and hematocrit levels.
Materials and Methods
Study group
Study protocol was approved by local ethics committee and 
all procedures performed were in accordance with the ethical 
standards of the institutional and/or national research commit-
tee and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards. Thirtyone healthy young 
adult volunteers (M/F, 15/16; mean age±SD, 20.7±1.7 years) 
were included to the study. Baseline evaluations included physi-
cal examination, electrocardiography, complete blood count and 
blood biochemistry including fasting blood glucose, urea, cre-
atinin, liver enzymes, and serum lipid profile. Exclusion criteria 
were positive family history for heart diseases, pathological find-
ings in electrocardiography such as arrhythmia and long QT, 
hypertension, musculoskeletal disorders, renal or hepatic dys-
function, peripheral vascular diseases, dyslipidemia, and regular 
medications. All participants underwent a 30-sec supramaximal 
exercise test by Wingate protocol. Pre- and post-exercise systolic 
and diastolic blood pressures (SBP and DBP), blood lactate and 
hematocrit levels were measured. Post-exercise measurements 
were performed within the 5th minute after the Wingate exer-
cise test. Venous blood samples were collected from antecubi-
tal vein into tubes with anticoagulant before and after exercise 
session. After cold centrifugation at 3000 rpm for 10 minutes, 
plasma samples aliquoted into Eppendorf tubes and stored at 
-80°C until assay. 
Supramaximal exercise test
The Wingate test comprised of a 30-sec supramaximal cycling 
against a resistance load. Test protocol can be find elsewhere 
(12). In brief, each test was performed on a cycle ergometer 
(Ergomedic 894-E, Monark, US). The load was determined for 
each subject according to body mass (0.075 kg x body weight in 
kg). Seat height was adjusted to each subject’s satisfaction and 
toe-clips were used to prevent the subject’s feet from slipping 
off the pedals. The warm-up period included 3-min pedalling 
against a 30 Watt constant load. By the command ‘start’ the par-
ticipant began pedalling as fast as possible until the end of the 
test period. Strong motivation was given verbally to subjects 
during the test.
Biochemical measurements
Plasma ANP and BNP measurements were done by radioimmu-
noassay whereas adiponection levels were determined by enzyme 
linked immunosorbent assay. Commercial kits were used for 
ANP (RK-005-06, Phoenix Pharmaceuticals, US), BNP (RK-011-
24, Phoenix Pharmaceuticals, US), and adiponectin (EK-ADI-01, 
Phoenix Pharmaceuticals, US) measurements based on leaflet 
inbox instructions. Blood lactate levels were measured by a port-
able lactate meter (Accutrend Plus, Cobas, Roche Diagnostics, 
Germany) and test strips (BM-Lactate, Ref. No: 0301654016, 
Cobas, Roche Diagnostics, Germany). Total cholesterol, high den-
sity lipoprotein, and triglyceride levels were measured by spectro-
photometry (Beckman Coulter). Low density lipoprotein-choles-
terol was calculated according to the Friedewald formula [total 
cholesterol-(triglyceride/5+ high density lipoprotein)]. Creatinine 
was evaluated by spectrophotometric autoanalyser (MEGA 600, 
Merck, Germany) using commercial kits (Diasis, Germany).
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Statistical analysis
All data were given as means and standard deviations un-
less otherwise indicated. Normal distribution of variables was 
tested by One Sample Kolmogorov Smirnov test. Comparison 
of mean values obtained pre- and post exercise measurements 
was performed by paired samples t-test for parametric variables, 
and Wilcoxon signed ranks test for non-parametric variables. 
Between group comparisons were made by t-test for paramet-
ric variables and Mann Whitney U test for non-parametric 
variables. The analysis of covariance test was used to test the 
difference between the mean percent changes in both gender 
groups. Relationship between hormones and hemodynamic 
measurements was tested by Spearman’s correlation analysis. A 
p value lower than 0.05 was accepted as statistically significant. 
Statistical analyses were performed by using the SPSS 20.0 (IBM 
SPSS Inc., Chicago, IL, USA) statistical software.
Results
General characteristics of the study group are given in Table 1. 
All measurements were within normal limits. The mean height, 
weight and body mass index values were significantly higher in 
male participants than in females. Fasting blood glucose and 
blood levels of urea and creatinin were also significantly higher 
in males than in females. Serum HDL level was significantly low-
er in men than in women (see Table 1 for details). Measurements 
during exercise test were given in Table 2. Male participants 
exerted higher power parameters than females. Wingate an-
aerobic exercise test led to significant increases in systolic and 
diastolic blood pressures in both gender (Male SBP, 125.4±8.4 
vs 161.1±23.8 mmHg, p<0.001; DBP, 68.6±6.9 vs 69.2±9.3 
mmHg, p>0.05; Female SBP, 114.4±7.6 vs 126.5±11.5 mmHg, 
p<0.05; DBP, 66.0±4.8 vs 67.8±6.6 mmHg, p>0.05). Heart rate 
changes before and after the test were also significant (Male, 








Age, yr 20.7±1.7 19.9±1.3 21.5±1.8*
Anthropometric
Height, m 1.70±0.07 1.66±0.05 1.75±0.05***
Weight, kg 65.2±12.4 56.2±4.7 74.8±10.8***
BMI, kg/m2 22.1±2.9 20.3±1.6 24.1±2.7***
Biochemical
FBG, mg/dL 88.4±15.5 80.9±13.0 96.5±14.2**
Urea, mg/dL 19.6±4.9 16.7±3.2 22.8±4.6***
Creatinin 0.70±0.10 0.67±0.06 0.87±0.08***
ALT, IU/L 22.1±17.0 16.3±6.4 28.2±22.2
AST, IU/L 27.3±13.5 23.3±4.6 31.7±18.2
TG, mg/dL 97.1±60.0 78.3±47.8 117.2±66.7
Cholesterol, mg/dL 162.5±32.1 165.0±34.6 159.8±30.2
HDL, mg/dL 50.5±16.2 61.0±11.9 39.3±12.3***
LDL, mg/dL 92.7±25.0 88.4±28.0 97.3±21.2
Abbreviations: BMI, body mass index; FBG, fasting blood glucose; ALT, alanine transaminase; AST, 
aspartate transaminase; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein. 
Comparisons were made between the both gender. *p<0.05; **p<0.01; ***p<0.001
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76±9 vs 119±15 min-1, p<0.001; Female, 82±15 vs 116±11 min-1, 
p<0.001). The mean plasma adiponectin levels before and after 
supramaximal exercise session were shown in Figure 1. A sin-
gle bout supramaximal exercise resulted in a significant increase 
in plasma adiponectin levels (Pre- and post-exercise adiponec-
tin, 17.45±4.70 μg/mL vs 31.29±5.16 μg/mL; p<0.001). Gender 
stratification had no effect on this change. Both male and female 
participants showed significant elevation in plasma adiponec-
tin levels (16.52±4.53 vs 30.99±4.56; 18.31±4.85 vs 31.57±5.80 
μg/mL; respectively, p<0.001 for both). Plasma ANP and BNP 
levels remained similar before and after supramaximal exercise 
(Figure 2 and 3). Both ANP and BNP levels were higher in fe-
male subjects during pre-exercise resting period. Supramaximal 
exercise test led to increase in ANP and BNP levels in females 
whereas it led to decrease in both natriuretic peptides in males. 
However, these changes did not reach to statistically significance 
level. Hematocrit levels significantly increased by the exercise in 
females and males (38.2±2.6 vs 39.3±5.8%, p<0.05 and 45.1±1.8 
vs 48.3±2.2%, p<0.001). Finally, blood lactate level increased 
significantly by the anaerobic exercise test in both female and 
Table 2. Supramaximal exercise results of the study group






Peak Power, W 660.3±206.5 482.8 ± 81.7 837.9 ± 118.9***
Peak Power, W/kg 9.89 ± 1.92 8.54 ± 1.38 11.25 ± 1.35***
Mean Power, W 468.3±14.89 343.0±56.8 593.6±95.4***
Mean Power, W/kg 6.98 ± 1.20 6.03 ± 0.67 7.93 ± 0.77***
Minimum Power, W 272.1 ± 113.7 193.0 ± 72.3 351.1 ± 90.2***
Minimum Power, W/kg 4.08 ± 1.36 3.52 ± 1.54 4.64 ± 0.87**
Abbreviation: W, Watt. Comparisons were made between the both gender. 
*p<0.05, **p<0.01, ***p<0.001, Mann Whitney U test.
Figure 1. Plasma adiponectine levels before and after supra-
maximal exercise. A single bout supramaximal exercise re-
sulted in a significant increase in plasma adiponectin levels in 
male and female subjects (p<0.001 for both).
Figure 2. Plasma atrial natriuretic peptide levels remained 
comparable before and after supramaximal exercise in male 
and female subjects.
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Figure 3. Plasma B-type natriuretic peptide levels remained 
comparable before and after supramaximal exercise in male 
and female subjects.
male participants (2.22±0.57 vs 8.58±2.16 and 2.46±1.56 vs 
10.90±2.91 mmol/L, p<0.001 for both). Correlation test revealed 
that systolic and diastolic blood pressure changes during exer-
cise was moderately correlated (p=0.02; r=0.41). Heart rate and 
diastolic blood pressure (p=0.04; r=0.37) and lactate and heart 
rate changes (p=0.01; r=0.43) were moderately correlated. ANP, 
BNP and adiponektin changes were not statistically correlated.
Discussion
The main finding of this study was a significant increase in 
plasma adiponectin levels following a 30-second supramaximal 
exercise test in both male and female subjects, whereas plasma 
ANP and BNP levels remained unchanged. Exercise induced 
changes of blood adiponectin were studied previously (13-17). 
Most of these studies involved long-term chronic exercise pro-
grams differed in terms of protocol which included male or fe-
male participants. In one of the earlier studies, overweight male 
participants underwent a 10-week exercise program comprised 
of two or three bouts of moderately intense aerobic exercise 
which caused 260% rise in adiponectin levels (16). In a follow-
ing study, young adult healthy females subjected to 30-60 min/
day aerobic exercise for 7 months which in turn led to significant 
increases in circulating adiponectin levels (15). Another study 
investigated effects of chronic aerobic training up to 9 months 
on plasma adiponectin levels and found no significant increase 
(14). The study group consisted of both male and female workers. 
There are also some other studies investigated the effects of acute 
exercise sessions on circulating adiponectin levels. Ferguson et 
al studied the effects of 60-min aerobic cycle ergometry exercise 
in healthy subjects and found no change in plasma adiponectin 
levels of both males and females (18). In a recent study, plas-
ma concentration of adiponectin was not changed in response 
to one session of acute resistance training (17). Furthermore, 
having history of regular training was not a significant factor 
of adiponectin response to exercise (17). Repeated bouts of su-
pramaximal exercise in healthy men resulted in a marked de-
crease in adiponectin level (13). In our study, participants un-
derwent only single bout 30-sec supramaximal exercise which 
led to almost 1.8-fold increase in circulating adiponectin levels. 
Similarly, plasma adiponectin levels showed a 20% increase fol-
lowing a 20-min acute intense rowing exercise (19). It is obvious 
that these studies are not comparable in terms of adiponectin 
response to acute exercise as each one of them used a different 
acute exercise protocol. Nevertheless, this study may suggest 
that adiponectin increases during the very early periods of acute 
exercise and then returns to pre-exercise levels.
Several putative mechanisms were suggested to explain the 
link between exercise and alterations in circulating adiponectin 
levels. Although adiponectin was originally described as an adi-
pokine, we now know that it is also secreted from muscle cells, 
thus also accepted as myokine (20-22). Adiponectin production 
in skeletal muscle increases in response to metabolic challenge 
(23) or acute inflammation caused by lipopolysaccharide injec-
tion (24). Acute heavy exercise results in immediate increases 
in proinflammatory cytokines such as interleukin-6 (13) and 
C-reactive protein (25) which in turn may induce adiponectin 
secretion from muscle fibers. Thus, exercise-induced adiponec-
tin rise in circulation may originate from muscle tissue rather 
than adipose tissue. However, to our knowledge no study has 
yet examined the mechanism of exercise-induced adiponectin 
increase.
Another mechanism may involve natriuretic peptides. 
Tsukamoto et al (26) in their mechanistic study, demonstrated 
that ANP and BNP enhance adiponectin secretion from cul-
tured human adipocytes. The same group also reported a sig-
nificant correlation between plasma adiponectin and BNP lev-
els in 1,538 healthy subjects (27). Furthermore, Birkenfeld and 
colleagues studied the effects of intravenous ANP infusion on 
systemic adiponectin levels in healthy men (28). They found that 
ANP acutely increased systemic total and high molecular weight 
adiponectin concentrations. With all this background, we meas-
ured circulating natriuretic peptides and adiponectin levels un-
der conditions of single bout supramaximal exercise. However, 
we failed to find any significant correlation between exercise-
induced ANP, BNP and adiponectin changes which suggests ad-
iponectin increase may not be related with natriuretic peptides.
We performed a gender-based stratification during the analy-
ses of data. Pre-exercise natriuretic peptide levels were higher 
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in female group whereas adiponectin levels were comparable in 
both groups. In this study, a 30-second supramaximal exercise 
was ineffective in altering serum ANP and BNP concentrations. 
However, natriuretic peptide response to exercise was slightly 
different in male group in which a trend of decrease was ob-
served both in ANP and BNP. In contrast, these were remained 
unchanged in female participants. Both male and female par-
ticipants showed similar pattern of increase in adiponectin re-
sponse to 30-sec supramaximal exercise.
In conclusion, this is the first study which evaluated adi-
ponectin, ANP and BNP levels before and after a 30-sec su-
pramaximal exercise in healthy female and male subjects. These 
results showed that a 30-sec supramaximal exercise session en-
hanced circulating adiponectin levels in both gender groups, 
whereas ANP and BNP levels exerted non-significant altera-
tions. We suggest that there may be two possibilities in explain-
ing adiponectin increase. First, adiponectin release in response 
to acute heavy exercise may stem from muscle cells rather than 
adipose cells. Second, adipocyte mediated adiponectin release 
may not involve natriuretic peptide secretion.
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